Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 71 for “"ERBB 2"”.
-
Characterization of overexpressed ERBB-2 in WBF-344 cells
This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).
-
Μελέτη της ογκοπρωτεΐνης c-erbB-2 στον πλακώδη τύπο καρκίνου του πνεύμονα.
Η ΠΡΟΓΝΩΣΤΙΚΗ ΣΗΜΑΣΙΑ ΤΗΣ ΕΚΦΡΑΣΗΣ ΤΟΥ c-erbB-2 ΓΟΝΙΔΙΟΥ ΣΤΟΝ ΜΗ ΜΙΚΡΟΚΥΤΤΑΡΙΚΟ ΚΑΡΚΙΝΟ ΤΟΥ ΠΝΕΥΜΟΝΑ ΠΑΡΑΜΕΝΕΙ ΑΔΙΕΥΚΡΙΝΙΣΤΗ.ΣΤΗΝ ΠΑΡΟΥΣΑ ΕΡΓΑΣΙΑ ΜΕΛΕΤΗΣΑΜΕ ΤΗΝ ΕΚΦΡΑΣΗ c-erbB-2 ΣΕ 107 ΑΣΘΕΝΕΙΣ ΜΕ ΠΡΩΙΜΟ (ΣΤΑΔΙΟ Ι/ΙΙ)ΜΗ ΜΙΚΡΟΚΥΤΤΑΡΙΚΟ ΚΑΡΚΙΝΟ ΤΟΥ ΠΝΕΥΜΟΝΑ (69 ΠΛΑΚΩΔΗ ΝΕΟΠΛΑΣΜΑΤΑ ΚΑΙ 38 …
-
Μοριακή ανάλυση του γονιδίου C-erbB-2 και αριθμητικών χρωμοσωματικών ανωμαλιών σε παθήσεις τραχήλου μήτρας
… 3, 7, 8 and 17 and the amplification of the c-erbB-2 oncogene, in precancerous lesions and invasive carcinomas of the cervix, using fluorescence in situ hybridization (FISH). We studied, also, the overexpression of the c-erbB-2 oncoprotein by immunohistochemistry. Formalin-fixed, …
-
Novel Role of ErbB-2 in Inhibition of Jagged-1-Mediated Trans-Activation of Notch in Breast Cancer
The ErbB-2 gene is amplified and the resulting protein product overexpressed in 15-30% of breast tumors, and associated with aggressive behavior and poor overall survival. Currently, there are two FDA approved therapies targeting ErbB-2 for the treatment of ErbB-2 positive breast cancer: …
-
Expressão imuno-histoquímica das oncoproteínas C-erbB-2 e Bcl-2 e das células de Langerhans em carcinoma epidermóide oral
… in order to evaluate the expression pattern of c-erbB-2 and bcl-2 proteins and Langerhans cells (S-100 positive cells) in these lesions. These immunohistochemical expressions have also been compared to the tumour anatomic site and histological grading of malignancy. We have found out a higher …
-
Histoquímica com lectinas para Tn e imunohistoquímica para c-erbB-2 na investigação do carcinoma ductal invasivo de mama (CDI)
… molécula de valor diagnóstico e prognóstico é c-erbB-2 que tem papel chave na proliferação, adesão, diferenciação e motilidade celular. O trabalho objetivou avaliar o perfil de N-aceti-galactosamina em glicoconjugados celulares empregando a histoquímica com lectinas e o perfil imunohistoquímico …
-
Ο ρόλος των μοριακών δεικτών DEK, SURVIVIN, P33ING1, MMP-2, C-ERBB-2 στην πρόγνωση του ουροθηλιακού καρκινώματος της ουροδόχου κύστεως
… the expression pattern of survivin, c-erbB-2, DEK, MMP-2 and P33ING1 in order to determine their potential prognostic significance. Since its discovery in 1997, survivin has garnered significant interest due to its putative role as an inhibitor of apoptosis. Few studies have …
-
Η σημασία της ενδοσκοπικά κατευθυνόμενης αναρροφητικής παρακέντησης με λεπτή βελόνη στη διάγνωση των νεοπλασμάτων του γαστρεντερικού σωλήνα: συγκριτική μελέτη της μεθόδου με τη βιοψία με ιστολαβίδα και την ψήκτρα
C-erbB-2 oncoprotein is a member of the family of epidermal growth factor receptors ( EGFR ). Overexpression of c-erbB-2 oncoprotein has been shown to be related with relapse and poor prognosis in adenocarcinomas of the breast and stomach. In pancreatic cancer the overexpression of c-erbB-2 …
-
Expression der Wachstumsfaktoren CR-1, TGF alpha und des Rezeptors erbB-2 im zervikalen Normalgewebe, der cervikalen intraepithelialen Neoplasie und im Plattenepithelkarzinom der humanen Zervix uteri
… Methoden die Expression von CR-1, TGF alpha und erbB-2 an 19 Normalgeweben, 27 CIN und 112 Plattenepithelkarzinomen der Zervix Uteri untersucht und diese mit klinischen Parametern und Überlebensdaten verglichen. CR-1 fand sich am normalen Zervixepithel an der Endozervix exprimiert. Im Karzinom …
-
Ανοσοϊστοχημικές παράμετροι στον καρκίνο του παχέος εντέρου σε σχέση με τη βιολογική του συμπεριφορά
… P53AND THE OVEREXPRESSION OF THE ONCOGENE C-ERBB-2 IN COLORECTAL CANCER TISSUE CELLS, CORRELATES WITH OTHER VARIABLES KNOWN TO AFFECT THE BIOLOGICAL BEHAVIOUR OF THE TUMOUR AND THE SURVIVAL OF THE PATIENTS. WE APPLIED IMMUNOHISTOCHEMICALTECHNIQUES, USING MONOCLONAL ANTIBODIES IN SECTIONS OF …
-
ΑΝΙΧΝΕΥΣΗ ΜΕ ΑΝΟΣΟΙΣΤΟΧΗΜΙΚΗ ΜΕΘΟΔΟ ΜΟΝΟΚΛΩΝΙΚΩΝ ΑΝΤΙΣΩΜΑΤΩΝ C-ERB B-2 ΚΑΙ P53 ΣΕ ΚΑΚΟΗΘΕΙΣ ΟΓΚΟΥΣ ΜΕΤΑΒΑΤΙΚΟΥ ΕΠΙΘΗΛΙΟΥ ΟΥΡΟΔΟΧΟΥ ΚΥΣΤΗΣ
… WERE STAINED WITH YUONOCLONAL ANTIBODY TO C-ERBB-2 AND TO P53 ONCOPROTEINS.RESPECTIVELY 69,5%(25/36)OF THE TCC,STAINED FOR C-ERBB-2 ONCOPROTEIN AND 40%(14 /36)STAINED FOR P53 ONCOPROTEIN.FROM THE 36 CASES,29 WERE PAPILLAR CANCER AND THE REWAINING7 CASES HAS BEEN SHOWN TO BE INVASIVE …
-
Tyrosine Kinase Growth Factors in Gastric Cancer
… of expression and prognostic value of EGFr and c-erbB-2 have been reported with some considerable variation using standard immunohistochemistry. To assess the use of growth factors as tumour markers or potential therapeutic targets, reliable quantitative and reproducible measurements of expression …
-
Mutational activation of the Neu receptor tyrosine kinase during mammary tumorigenesis in the transgenic mice
<p>Overexpression of the Neu/ErbB-2 receptor has been implicated in the genesis of human breast cancer. Indeed, transgenic mice expressing the neu proto-oncogene develop focal tumors arising next to hyperplastic mammary epithelium after a long latency period. Induction of mammary tumors in these …
Page 1 of 4